A phase IB study of durvalumab with or without tremelimumab and platinum-doublet chemotherapy in advanced solid tumours: Canadian Cancer Trials Group Study IND226

Rosalyn A. Juergens, Desirée Hao, Peter M. Ellis, Dongsheng Tu, Mihaela Mates, Christian Kollmannsberger, Penelope A. Bradbury, Moustapha Tehfe, Paul Wheatley‐Price, Andrew Robinson, Gwyn Bebb, Janessa Laskin, John R. Goffin, John Hilton, Anna Tomiak, Sebastién J. Hotte, Glenwood Goss, Pamela Brown-Walker, Xiaoqun Sun, Ming‐Sound Tsao, Michael Cabanero, Isabelle Gauthier, Xuyang Song, Phillip A. Dennis, Lesley Seymour, Martin Smoragiewicz, Scott A. Laurie